Physician profile
Gilbert Endriga
NPI 1790465243
$1,959.71
in general payments reported to CMS, 2019-2025
16 companies · $1,366 in 2025
The $1,366 reported for 2025 was more than what 89% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $196 · 2024: $398 · 2025: $1,366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,959.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $423.34 | 2023-2025 | Ozempic, Wegovy |
| Insulet Corporation | $324.09 | 2024-2025 | Omnipod |
| Medtronic, INC. | $265.84 | 2023-2025 | Minimed 780g, Mycarelink |
| Amgen INC. | $183.04 | 2025 | Evenity, Repatha |
| Sequel Med Tech, LLC | $171.78 | 2025 | Twiist |
| Madrigal Pharmaceuticals | $137.02 | 2025 | Rezdiffra |
| Lilly USA, LLC | $76.59 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $66.67 | 2023-2025 | |
| Rhythm Pharmaceuticals, INC. | $66.40 | 2025 | Imcivree |
| Xeris Pharmaceuticals, INC. | $57.29 | 2025 | Gvoke Hypopen, Recorlev |
| Intra-Sana Laboratories | $50.66 | 2023 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Recordati_rare_diseases_inc. | $43.06 | 2025 | Isturisa |
| Mannkind Corporation | $39.67 | 2023-2024 | Afrezza |
| Ionis Pharmaceuticals, INC. | $20.08 | 2025 | Tryngolza |
| Radius Health, INC. | $19.42 | 2025 | Binosto, Tymlos |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $14.76 | 2024 | Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilbert Endriga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.